New York Confronts Second-Wave Risk: Visitors From Florida and Texas
Shawdesh desk: New York, once the center of the coronavirus pandemic, has so successfully stemmed the outbreak that its death and hospitalization rates have plummeted and it has among the ReadMore
What to Know About N.Y.’s Traveler Restrictions
Shawdesh desk: New York, once an epicenter of the coronavirus pandemic, is further tightening its restrictions on visitors from the current hot spots across the country. Starting today, travelers from ReadMore
He Beat Trump and Weinstein. Why Is This D.A.’s Standing Still Shaky?
Shawdesh desk: He just won a landmark victory in the Supreme Court over President Trump that paved the way for prosecutors to obtain the president’s tax returns. In February, he ReadMore
Coronavirus: US records 34,79,483 cases, 138,247 deaths
Shawdesh Desk; The coronavirus has killed 138,247 people in United States at 14:00 pm till Tuesday (Bangladesh Time), according to latest data from worldometer. While 34,79,483 coronavirus infected patients have been detected, 15,49,469 COVID-19 patients have ReadMore
India coronavirus death toll climbs to 23,727
Shawdesh desk: India has recorded 23,727 coronavirus deaths from 907,645 cases at 12:00pm till Tuesday, according to latest data from worldometer. So far, 572,112 patients have been considered recovered from the contagious virus while 311,806 are active cases, ReadMore
Latin America now second-worst region for virus deaths
Shawdesh desk: Latin America surged past the United States and Canada on Monday to become the second-worst affected region in the world for coronavirus deaths, according to an AFP tally. ReadMore
Coronavirus: Global death toll hits 575,545
Shawdesh desk: The global death toll from coronavirus stood at 575,545 at 10:40 am till Tuesday (Bangladesh Time), according to latest data from worldometer. So far, 1,32,38,121 people have been diagnosed with coronavirus while 76,98,371 patients ReadMore
Aussie COVID-19 vaccine begins human trials
Shawdesh desk: A COVID-19 vaccine under development by Australia’s University of Queensland (UQ) has commenced human trials, officials announced Monday. Phase 1 of the trial will involve around 120 volunteers ReadMore
